Metabolism of PGP peptide after administration via different routes

Bulletin of Experimental Biology and Medicine

Volumn 135, Issue 4, 2003, Pages 361-364

  Zolotarev, Yu A ^a   Zhuikova, S E ^b   Ashmarin, I P ^b   Myasoedov, N F ^a   Vas'kovskii, B V ^c   Samonina, G E ^b  

^a INSTITUTE OF MOLECULAR GENETICS   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

Author keywords

Glyprolines; Metabolites; Oligopeptides

Indexed keywords

DIPEPTIDE; DRUG METABOLITE; GLYCOPROTEIN P; PEPTIDOGLYCAN; TRIPEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG DETERMINATION; DRUG METABOLISM; DRUG PENETRATION; DRUG RELEASE; DRUG STABILITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; PHARMACOLOGICAL PARAMETERS; RABBIT;

ANIMALS; DRUG ADMINISTRATION ROUTES; FEMALE; PEPTIDES; RABBITS; TRITIUM;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0141816922     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024612831380     Document Type: Article

References (14)

1. M. A. Abramova, G. E. Samonina, and I. P. Ashmarin, Neirokhimiya, 13, No. 3, 209-214 (1996).
2. M. A. Abramova, G. E. Samonina, Ch. V. Mamedov, et al., Vestn. Moskovsk. Universiteta, Ser. Biology, No. 2, 7-10 (1997).
3. I. P. Ashmarin, A. A. Kamenskii, L. A. Lyapina, et al., Vopr. Biol. Med. Farmatsevtich. Khim., No. 1, 24-27 (2002).
4. I. P. Ashmarin, E. P. Karazeeva, L. A. Lyapina, et al., Biokhimiya, 63, No. 2, 149-155 (1998).
5. I. P. Ashmarin, V. E. Pastorova, and L. A. Lyapina, Byull. Eksp. Biol. Med., 125, No. 5, 496-499 (1998).
6. S. E. Zhuikova, L. A. Smirnova, Z. V. Bakaeva, et al., Ibid., 129, No. 10, 300-302 (2000).
7. G. E. Samonina, G. N. Kopylova, V. I. Sergeev, et al., 87, No. 11, 1488-1492 (2001).
8. N. M. Timofeeva, N. N. Iezuitova, and L. V. Gromova, Uspekhi Fiziol. Nauk, 31, No. 4, 24-37 (2000).
9. D. F. Cunningham and B. O'Connor, Biochim. Biophys. Acta, 1343, No. 2, 160-186 (1997).
10. M. L. Gardner, Annu. Rev. Nutr., 8, 329-350 (1988).
11. S. Muller, R. Dunker, and G. Hochhaus, Pharmazie, 51, No. 8, 581-585 (1996).
12. G. Samonina, L. Lyapina, G. Kopylova, et al., Pathophysiology, 7, No. 1, 69-73 (2000).
13. D. Walker, D. T. Thwaites, N. L. Simmons, et al., J. Physiol., 507, Pt. 3, 697-706 (1998).
14. Y. Yamamoto, Y. Tsutsumi, and T. Mayumi, Curr. Drug Targets, 3, No. 2, 123-130 (2002).